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Thirty-six of 36 strains of Enterobacter cloacae and E. aerogenes with inducible (-lactamase developed
resistance when cefoxitin (inducer) was added to cefuroxime disks. Constitutive 1-lactamase producers (n =
23) were all resistant to cefuroxime. Cefuroxime resistance correlated with the amount of induced or
constitutive P-lactamase. Cefuroxime was a better indicator of induced resistance than cefamandole, cefazolin,
cephalothin, ceftriaxone, cefotaxime, ticarcillin with or without clavulanic acid, or cefotetan. Induction by
addition of cefoxitin to disks occasionally reduced zone sizes but not enough to change interpretations for
ceftazidime, ceftizoxime, aztreonam, cefoperazone with or without sulbactam, and piperacillin with or without
tazobactam. Most enterobacters were resistant to cefmetazole. The cefoxitin inducer-cefuroxime indicator
method can be used in routine clinical laboratories to detect latent resistance due to chromosomally mediated
inducible js-lactamase in enterobacters.
Enterobacters and many other gram-negative bacilli carry a
gene for a chromosomally encoded 1-lactamase which can be
induced by certain antibiotics, amino acids, or body fluids (4,
6). It is a concern that organisms harboring genes for inducible
,B-lactamases may show false susceptibility if tested in the
uninduced state (14). Therapeutic failures with antibiotics to
which organisms were initially susceptible have been reported
(2, 13, 16, 17). Several methodologies for laboratory detection
of inducible resistance have been suggested. Sanders and
Sanders (15) proposed a disk approximation test in which
cefoxitin (inducer) disks were placed adjacent to antibiotic test
disks. If the test zones were flattened by .4 mm by the
adjacent inducer disk, the organism was said to have inducible
resistance. Recently, Nadal and von Graevenitz (10) suggested
routine use of the disk approximation test employing cefoxitin
disks dispensed at standard distances and that a .1-mm
truncation of zones indicates resistance. Addition of cefoxitin
to microtiter dilution (9, 12) and agar dilution (8) susceptibility
tests has had limited success. To establish a standardized,
reproducible, and therefore interpretable method, we devised
a method for measuring induced resistance by using the
standard disk diffusion susceptibility test method modified by
adding the inducer to test disks.
MATERIALS AND METHODS
Selection of isolates. Thirty-one enterobacter strains were
collected as consecutive nonduplicate clinical isolates at the
Olin E. Teague Veterans' Center microbiology laboratory
from December 1989 to March 1990. Twenty-nine enter-
obacter strains from blood, cerebrospinal fluid, intravenous
sites, and wounds were collected at the St. Louis University
Hospital, St. Louis, Mo., from October 1991 to November
1992. Enterobacter cloacae 55 and 55M were received from
Christine Sanders, Creighton University, Omaha, Nebr., and
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used as controls for inducible and constitutive (stably dere-
pressed) 1-lactamase producers. Significant information about
each of the 62 organisms is summarized in Table 1. Organisms
were stored at -50°C in Trypticase soy broth glycerol vials
(Pro-Lab Diagnostics, Round Rock, Tex.).
Growth of inocula. A bead from frozen vials was roll
inoculated onto MacConkey's agar to revive the organisms. All
organisms were subcultured at least once prior to susceptibility
testing.
Induction of P-lactamase. Overnight Trypticase soy broth
cultures were inoculated 1:100 into 10 ml of Trypticase soy
broth and incubated on a reciprocal shaker (200 rpm) at 35°C.
Cefoxitin was added to 3-h Trypticase soy broth cultures to
achieve a final concentration of 0, 5, or 30 ,ug/ml, and
incubation was continued to 4 h. Organisms were harvested
from 4-h cultures by centrifugation at 2,000 x g for 10 min,
washed three times in 10 ml of 0.1 M phosphate-buffered saline
(pH 7.3), and resuspended in phosphate-buffered saline to 1/10
of the original volume.
Sonic disruption of organisms. Washed organisms were
sonically disrupted with a W-375 Cell Disruptor (Heat Systems
Ultrasonics, Inc., Plainview, N.Y.) or a Fisher 300 Sonic
Dismembrator (Imaging Products International, Chantilly,
Va.) at maximum output for 2 min. Materials were sonicated in
an ice bath to prevent thermal denaturation of enzymes.
Sonicates were sedimented at 2,000 x g for 15 min. The
supernatant fluid and sediments were separated and frozen at
-20°C pending protein and ,B-lactamase assay.
Protein assay. Protein concentration was determined with a
bicinchoninic acid assay (Sigma, St. Louis, Mo.) modified for
testing on a Technicon RA-1000 autoanalyzer. The following
parameters were determined to be optimal for the assay:
TYPE, 1; %SMP VOL, 60; FILTER POS, 5 WL550; DELAY,
0 30; INCUBATION, 8 30; %RGT VOL, 65; UNITS, 15
jig/ml; UNIT FAC, 1.0000; DECIMAL PT, 0; RBL LOW,
0.000; RBL HI, 3.000; RANGE LOW, 0; RANGE HI, 2500;
NORMAL LO, 0; NORMAL HI, 2000; SLOPE, 1.000; IN-
TERCPT, 0.0000; LIN FACT, 5.00; 1ST LIM, 0.0453. Protein
concentrations ranging from 25 to 4,000 j,g/ml could be
measured.
,-Lactamase assay. ,B-Lactamase activity was detected with
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TABLE 1. Source, classification, and inducible resistance of organisms
Strain Source Type P-Lactamase activity (U/mg of protein) Induced resistance toa:Basal Induced
E. cloacae U97
E. cloacae U66
E. aerogenes 1088A
E. cloacae 058
E. cloacae 0102
E. cloacae 057
E. cloacae 025
E. cloacae U101
E. cloacae U67
E. cloacae U61A
E. cloacae U19
E. cloacae U13
E. cloacae 060
E. cloacae U57
E. cloacae 06
E. cloacae U7
E. cloacae 034
E. cloacae 020
E. cloacae U21
E. cloacae U60
E. cloacae 030
E. cloacae 55
E. cloacae 999
E. cloacae 2271
E. cloacae 767
E. cloacae 408
E. cloacae 232
E. cloacae 230
E. aerogenes 039
E. aerogenes 026
E. aerogenes 023
E. aerogenes U27
E. aerogenes U24
E. aerogenes U40
E. aerogenes 2158
E. aerogenes 2051-2
E. aerogenes 369
E. aerogenes 292
E. aerogenes 273
E. cloacae U61B
E. cloacae U6
E. cloacae Ul
E. cloacae 019
E. cloacae SSM
E. cloacae 1759
E. cloacae 1758
E. cloacae 1006
E. cloacae 886
E. cloacae 845
E. cloacae 586
E. cloacae 458
E. cloacae 457
E. cloacae 425
E. aerogenes 016
E. aerogenes 2051-1
E. aerogenes 2034-2
E. aerogenes 2034-1
E. aerogenes 1088B
E. aerogenes 517-2
E. aerogenes 517-1
E. aerogenes 422
E. aerogenes 196
Urine
Urine
Wound
Sputum
Sputum
Foot
Unknown
Urine
Urine
Urine
Urine
Urine
Sputum
Urine
Knee
Urine
Leg
Groin
Urine
Urine
Hand
C. Sanders
Blood
Blood
i.v.C
Skin
Tissue
i.v.
Sputum
Sputum
Sputum
Urine
Urine
Urine
Blood
CSFd
CSF
CSF
CSF
Urine
Urine
Urine
Elbow
C. Sanders
Blood
Blood
i.v.
i.v.
i.v.
i.v.
Blood
Blood
Tissue
Sputum
CSF
CSF
CSF
Wound
CSF
CSF
Unknown
Blood
Lb
L
L
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
0
17
23
62
31
28
110
85
15
191
111
15
26
17
19
87
20
32
42
58
84
31
46
21
87
8
24
146
25
67
120
36
27
67
92
0
50
62
59
12,014
5,648
275
2,332
6,951
839
841
3,515
4,325
7,520
1,968
2,347
8,646
4,783
205
1,982
1,441
2,871
1,982
10,732
5,443
2,120
1,381
190
744
0
6,323
3,270
2,903
1,457
7,750
1,370
9,236
3,841
3,394
2,343
2,126
3,174
1,516
3,050
3,882
2,686
2,746
2,604
2,014
1,692
6,105
6,275
4,531
6,287
11,750
2,346
6,885
5,157
2,133
1,814
3,453
2,788
5,361
3,541
4,249
3,219
58,124
3,241
3,090
5,118
18,323
4,630
3,161
6,576
9,167
8,773
7,894
6,364
7,293
2,984
10,000
9,724
1,531
14,803
8,485
23,489
17,808
5,692
3,956
CF
CXM, MA, TIC, TIM
CXM
CXM, MA
CXM, MA
CXM, MA
CXM
CXM, MA, CTT, TIM
CXM
CXM, MA, CTX, TIM
CXM, CRO
CXM, MA
CXM, MA
CXM, MA
CXM, CRO, CTX, TIM, CTT
CXM, MA, CTT, CRO
CXM, CF
CXM
CXM, CZ
CXM, MA
CXM
CXM, MA, TIM
CXM, MA
CXM, MA, TIC
CXM, MA
CXM, MA, TIM, CTT
CXM, MA
CXM, CZ
CXM
CXM, MA
CXM, CZ
CXM
CXM, MA
CXM, TIM
CXM, CZ
CXM, CZ
CXM, CZ
ATM, CAZ
CRO, CAZ, TIC
c Abbreviations: CF, cephalothin; CXM, cefuroxime; MA, cefamandole; TIC, ticarcillin; TIM, ticarcillin-clavulanic acid; CTT, cefotetan; CRO, ceftriaxone; CTX,
cefotaxime; CZ, cefazolin; ATM, aztreonam; CAZ, ceftazidime.
b Types: L, low producer; I, inducible; C, constitutive. Strain designations with no prefix letter were collected at the St. Louis University Hospital, except 55 and 55M,
which were received from C. Sanders, Creighton University School of Medicine.
C i.v., intravenous catheter.
d CSF, cerebrospinal fluid.
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i0' M CENTA (Calbiochem, San Diego, Calif.) (7) as the
substrate and a user-defined enzyme rate assay with a Techni-
con RA-1000 autoanalyzer. The following instrument param-
eters were used: TYPE, 0; %SMP VOL, 60; FILTER POS, 3
WL405; DELAY, 0 15; %RGT VOL, 76; UNITS, 3 U/liter;
UNIT FAC, 1.0000; DECIMAL PT, 0; RBL LOW, 0.000; RBL
HI, 3.000; RANGE LO, 25; RANGE HI, 5000; CAL FAC-
TOR, 2466.28; RGRT RATE, 0.0009; NORMAL LO, 25;
NORMAL HI, 250; SLOPE, 1.000; INTERCPT, 0.0000;
C1*10E-6, 9999.00; C2*10E-6, 9999.00; D1*10E-6, 9999.00;
DELTA no., 0.020. The measured threshold of detection was S
U, but precision was achieved in the range of 25 to 250 U.
Out-of-range samples (>250 U of activity) were appropriately
diluted prior to the final assay. A unit of ,-lactamase was
defined as the amount of enzyme required to degrade 1 jimol
of CENTA per min at 37°C and pH 7.3. Standard concentra-
tions ranging from 25 to 200 U of type I penicillinase from
Bacillus cereus (Sigma) were used to verify performance on
each test day.
Specific (8-lactamase activity. Specific 3-lactamase activity
was defined as units of 1-lactamase per milligram of protein.
Selection of indicator antibiotic. Standardized suspensions
prepared from colonies of enterobacters in the stationary
phase were streaked onto Mueller-Hinton agar in accordance
with standard disk diffusion susceptibility procedures (11).
Disks containing cefuroxime, cephalothin, cefamandole, cefa-
zolin, ceftriaxone, cefotaxime, ceftazidime, ceftizoxime, ce-
fotetan, cefmetazole, cefoperazone, cefoperazone-sulbactam,
aztreonam, ticarcillin, ticarcillin-clavulanic acid, piperacillin,
and piperacillin-tazobactam were applied to duplicate plates to
determine which antibiotic most effectively demonstrated in-
ducible resistance. Thirty micrograms of cefoxitin in 5 pl of
sterile water was then delivered by micropipette with a sterile,
disposable tip to disks on the induction plates. Disks on control
plates received 5 R1 of sterile water. Zones were measured and
interpreted by using standard methods (11). Cefoperazone-
sulbactam disks obtained from Pfizer Laboratories, New York,
N.Y., contained 75 ,ug of cefoperazone and 30 jig of sulbactam.
Interpretations (susceptible, .21 mm; resistant -15 mm) were
done as described by Barry et al. (1). Piperacillin-tazobactam
disks with 100 and 10 ,ug, respectively, now marketed as Zosyn,
were obtained from Lederle Laboratories, Pearl River, N.Y.
Determination of inducer concentration. Each inoculum was
prepared and swabbed onto 100-mm-diameter Mueller-Hinton
agar plates in accordance with standard disk diffusion methods
(11). Replicate disks were dispensed onto induction plates and
control plates. Cefoxitin at 0, 1, 5, 10, 20, or 30 jig in 5 ,ul of
sterile water was dispensed onto inducer plate disks. No
cefoxitin was added to disks on control plates. Zone sizes were
measured and interpreted by using standard methods (11).
RESULTS
Selection of an antimicrobial agent as an indicator of
resistance due to inducible f-lactamase. The effect of induc-
ible P-lactamase on 17 different antimicrobial agents was
evaluated by using disks with and without addition of 30 ,ug of
cefoxitin and 36 enterobacter strains with inducible enzymes.
The data in Fig. 1 show the antimicrobial agents to which
resistance could be induced. Cefuroxime was the best indicator
of cefoxitin-induced resistance. Thirty-five of 36 enterobacter
isolates with inducible ,3-lactamase were susceptible or inter-
mediately susceptible to cefuroxime control disks but resistant
when 30 jig of cefoxitin was added to the disks prior to
incubation. One isolate, E. aerogenes U24, gave zone sizes of 23
(susceptible) and 16 (intermediately susceptible) mm when
100
H 9o
z
< 80
(0 70
C060
Cr 50
40
W 30
C 20
XL 10
0
FOX
INDICATOR ANTIMICROBIAL
FIG. 1. Effect of cefoxitin (FOX) on disk diffusion interpretations
for 36 enterobacters with inducible ,B-lactamase. Antimicrobial agents
with indicator potential: cefuroxime (CXM), cefamandole (MA),
ceftriaxone (CRO), cefotaxime (CTX), cefotetan (C1T), and ticarcil-
lin without and with clavulanic acid (TICMM). The results obtained
with ticarcillin with and without clavulanic acid were identical.
tested against cefuroxime without and with added cefoxitin,
respectively. Cefamandole was the next best indicator but
appeared to be more refractory to degradation by induced
,B-lactamase. Although induction sometimes reduced the zone
sizes obtained with other effective antibiotics, interpretations
usually remained in the susceptible range. The identical results
obtained for ticarcillin and ticarcillin-clavulanic acid reflect the
inability of clavulanic acid to inhibit inducible ,B-lactamase.
Antibiotics which were ineffective indicators of induction are
not shown in Fig. 1. Cefazolin, cephalothin, and cefmetazole
were ineffective indicators because the enterobacter isolates
tested were too often resistant prior to induction. Susceptibility
to ceftazidime, ceftizoxime, aztreonam, cefoperazone with and
without sulbactam, and piperacillin with and without tazobac-
tam was constant regardless of induction.
Illustration of induced resistance. Figure 2 shows the disk
diffusion zone of a typical inducible organism exposed to
cefuroxime and the resistance which emerged upon addition of
a solution containing 30 jig of cefoxitin to a 30-jig cefuroxime
disk.
Effect of induction on constitutive P-lactamase producers.
The effect of induction was measured with 17 antimicrobial
agents and 23 enterobacter strains which produced 1-lacta-
mase constitutively. The data in Fig. 3 show that constitutive
enterobacters were much more resistant to 3-lactam antibiot-
ics than were the inducible strains shown in Fig. 1. The data
shown in Fig. 3 for the cefoperazone-sulbactam combination
and cefoperazone alone suggest that sulbactam inhibits 3-lac-
tamase in constitutive enterobacters. All constitutive organ-
isms were resistant to cefuroxime, cefamandole, cefazolin,
cephalothin, cefmetazole, ceftizoxime, and ticarcillin with and
without clavulanic acid regardless of induction.
Effect of induction on noninducible, nonconstitutive enter-
obacters. Organisms with baseline ,-lactamase levels of <25
U, induced ,B-lactamase levels of <750 U, and no inducible
resistance to cefuroxime were classified as low producers. Only
3 of 62 enterobacter strains in our collection fit the low-
producer category. Addition of cefoxitin to cefuroxime disks
failed to decrease the zone sizes of low producers (see Fig. 6).
Baseline 13-lactamase levels in inducible, constitutive, and
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FIG. 2. Typical appearance of cefuroxime susceptibility with and
without cefoxitin when testing an enterobacter with inducible P3-lacta-
mase. The labels 0 and 30 indicate the amounts (in micrograms) of
cefoxitin added to 30-[Lg cefuroxime (CXM) disks. Note that addition
of cefoxitin led to cefuroxime resistance (left) and flattening of the
susceptibility zone around the neighboring disk (right).
low-producer enterobacter isolates. 13-Lactamase was mea-
sured in uninduced enterobacter isolates to determine baseline
levels. The distribution curves in Fig. 4 show that high baseline
13-lactamase levels occurred more frequently in constitutive
organisms. All enterobacter strains with baseline enzyme spe-
cific activity below 200 U were susceptible to cefuroxime, and
those with activity over 200 U were resistant.
Average IP-lactamase activity in induced and uninduced
enterobacter groups. 13-Lactamase was measured in induced
and uninduced enterobacters. Average baseline and induced
cr-
w
z
20-
18-
16
14
12
_ _
10
- -
_
8
4- .--
-- ----
2
0 0 50 100150200250500 1K 5K>5K>13K
SPECIFIC BETA-LACTAMASE ACTIVITY
FIG. 4. Distribution of baseline, i.e., uninduced, specific 13-lacta-
mase activity in enterobacters which produce low levels despite
induction (-; n = 3), are inducible (O; n = 36), or produce
,B-lactamase constitutively (A; n = 23). Specific 1-lactamase activitv is
expressed in units of ,B-lactamase per milligram of protein.
3-lactamase levels for the inducible, constitutive, and low-
producer groups are shown in Fig. 5. Increases in 3-lactamase
occurred with cefoxitin exposure in all groups. Increases in
r-lactamase were concomitant with cefuroxime resistance in
inducible organisms. 3-Lactamase production among low pro-
ducers was not sufficient for cefuroxime resistance. Constitu-
tive strains produced more 3-lactamase when grown with an
inducer, but resistance was not a predictable consequence with
any antibiotic.
The sources and identities of the isolates studied are listed in
Table 1, which summarizes the abilities of individual isolates to
respond to cefoxitin induction with (i) 1-lactamase production
and (ii) the corresponding resistance(s).
Titration of inducer concentration. A range of cefoxitin
concentrations was tested to determine the most effective
inducer dose. The curves in Fig. 6 show the effect of the
cefoxitin concentration on average zone sizes among the three
groups of enterobacters tested versus cefuroxime. Organisms
z 80 111 1|1 L
10-
co 60ll| l
50
P&C T&Z CR0 CTX P-T ATM CFP SUL
INDICATOR ANTIMICROBIAL
FIG. 3. Effect of cefoxitin (FOX) on the resistance of 23 enter-
obacters which produce t-lactamase constitutively. Disk diffusion
results obtained with the following antimicrobial agents are shown:
piperacillin and cefotetan (P&C), ticarcillin and ceftazidime (T&Z),
ceftriaxone (CR0), cefotaxime (CTX), piperacillin with tazobactam
(P-T), aztreonam (ATM), cefoperazone (CFP), and cefoperazone with
sulbactam (SUL). Piperacillin and cefotetan were tested separately
but the results are combined in the P&C bar because they were
identical, as were the ticarcillin and ceftazidime results.
>
F:
w
cn
C)0
LLc-
w
0-
Co
m7c (n=23)b (n=36)
l(n=3)5
CEFOXITIN ug/mL
FIG. 5. Effect of induction on the average ,B-lactamase specific
activity in low 3-lactamase-producing (a), inducible (b), and constitu-
tive (c) groups of enterobacters. Specific activity ranges: a, low
producers (0 to 23, 59, and 0 to 311 U/mg of protein) b, inducible (0 to
199, 329 to 4,017, and 1,370 to 11,750 U/mg of protein) c, constitutive (205
to 12,014, 1,235 to 32,922, and 1,531 to 58,124 U/mg of protein). The
organisms were grown in 0, 5, and 30 ,ug of cefoxitin per ml, respectively.
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FIG. 6. Effect of cefoxitin on sizes of cefuroxime-produced zone
around enterobacters with respect to the ~-lactamase production type.
a, low producers (n = 3), b, inducible (n = 36), and c, constitutive (n
= 23). Cefoxitin was added in 5 pu.1.
in the inducible group showed a dose-response curve indicating
that 30 ,ug of cefoxitin is optimal for expression of resistance.
Testing of inducible strains E. aerogenes U24 and E. cloacae 55
showed that cefuroxime zones of inhibition did not decrease
further with 40, 60, 80, 90, or 120 ,ug of cefoxitin. The zone of
inhibition for E. cloacae 55 was 0 with 10 to 40 ,ug of cefoxitin
but increased to 7 mm with 60 ,ug and to 10 mm with 120 ,ug.
DISCUSSION
In a recent review, Ehrhardt and Sanders (5) described five
genes involved in ~-lactamase production and regulation in
enterobacters. Two genes, ampE and ampG, are believed to
encode products involved with the induction process, but the
exact mechanism is unknown. ampC encodes 3-lactamase.
ampR encodes a regulatory protein which enhances ampC
expression in the presence of an inducing signal. Wild-type
enterobacters are inducible, and mutants lacking ampR are not
inducible. ampD encodes a repressor. Mutants lacking ampD
are stably derepressed enterobacters which produce high levels
of ,B-lactamase constitutively and are probably selected for by
many ~-lactam antibiotics to which they are resistant. Ehrhardt
and Sanders (5) have postulated that the frequency of consti-
tutive resistance may be related to antibiotic selective pressure
in a hospital or a community. Enterobacters which produced
3-lactamase constitutively constituted only 16% of the Olin E.
Teague Veterans' Hospital consecutive isolates but 59% of the
St. Louis University Hospital enterobacters collected from
serious infections and treatment failures. While a concern,
resistance in constitutive organisms is expressed in standard
susceptibility tests but wild-type organisms can spuriously
appear to be susceptible if an inducer is not present to activate
upregulation of ampC by the ampR gene.
Disk approximation has been the most widely used test for
detection of resistance due to inducible ,B-lactamase. Sanders
and Sanders (15) used cefoxitin as an inducer and cefamandole
disks as indicators. Thore et al. (19) proposed cefotaxime as
the indicator antimicrobial agent. Nadal and von Graevenitz
(10) proposed interposing cefoxitin inducer disks with the
expanded-spectrum cephalosporins ceftazidime, ceftriaxone,
cefotaxime, and latamoxef. Cefamandole detected resistance
in 88% of inducible enterobacters as judged by .4-mm zone
flattening (15). Thore et al. (19) reported that 90% of enter-
obacters gave -1-mm zone truncation with cefotaxime when
induced with imipenem or cefoxitin (combined data). Repro-
ducibility was 80 and 81% for imipenem and cefoxitin, respec-
tively. Also using cefoxitin induction and the 1-mm criterion,
Nadal and von Graevenitz (10) reported that 88% of enter-
obacters had inducible resistance to at least one of four
expanded-spectrum cephalosporins tested, the best indicator
being ceftazidime, which detected resistance in 51%. Problems
with disk approximation include the distance between disks,
the strength of the inducer, the choice of indicator antimicro-
bial agent, and the degree of zone truncation needed to
correlate with resistance. The test we have described allows
interpretation of resistance on the basis of National Commit-
tee for Clinical Laboratory Standards criteria for disk diffusion
testing (11). Inducible enterobacters were susceptible to cefu-
roxime in the uninduced state but when induced they usually
showed absolutely no zone of inhibition with cefuroxime
susceptibility test disks. Cefoxitin-induced cefuroxime resis-
tance correlated perfectly with 1-lactamase inducibility in
enterobacters.
The use of disk approximation to detect inducible P-lacta-
mases in Pseudomonas sp., Serratia sp., Providencia sp., Mor-
ganella sp., and Proteus vulgaris has been reported (10, 15, 19).
Our cefoxitin inducer-cefuroxime indicator method detected
resistance in zero of nine Providencia, zero of five Pseudomo-
nas, one of two Morganella, and one of four Serratia strains.
Resistance in Serratia and Morganella strains emerged with 1
,ug of cefoxitin, but organisms became as susceptible as con-
trols with as little as 5 or 10 jig because, unlike enterobacters,
these isolates were susceptible to cefoxitin. All pseudomonads
were resistant to cefuroxime prior to induction, obviating its
use as an indicator. Perhaps a similar method with a different
inducer(s) and/or indicator(s) can be found to measure induc-
ible resistance in non-enterobacter organisms definitively.
Isolates 1088 and U61 initially gave discordant results with
respect to P-lactamase production type and cefuroxime sus-
ceptibility. The discordant cultures were found to consist of
heterogeneous populations which could be separated as fol-
lows: E. aerogenes 1088, E. aerogenes 1088A (low ,-lactamase,
not inducible, maintained susceptibility to cefuroxime and
cefoxitin) and 1088B (constitutive, consistently resistant to
cefuroxime and other P-lactam antibiotics); E. cloacae U61, E.
cloacae U61A (inducible, resistant to cefuroxime only when
induced) and U61B (constitutive, persistently resistant to
cefuroxime and other 1-lactams antibiotics). These two exam-
ples indicate that mixed populations with respect to P-lacta-
mase production and resistance may be common among
enterobacters and that constitutive mutants may arise from
highly susceptible weak 3-lactamase producers, as well as
inducible organisms. Use of the progeny of a single colony for
all tests minimized discordant results due to heterogeneous
populations that seemed to arise spontaneously.
If reduction of zone size is related to substrate specificity,
then it appears that inducible ,-lactamase(s) most readily
hydrolyzes cefmetazole, cephalothin, cefazolin, cefuroxime,
cefamandole, ceftriaxone, cefotaxime, cefotetan, ticarcillin,
ceftizoxime, aztreonam, and ceftazidime while cefoperazone
and piperacillin are resistant to hydrolysis. Preliminary data
obtained with crude lysates agree with the above order, except
that hydrolysis of cefuroxime appears to be slower than that of
cefamandole.
In the light of the findings of Ehrhardt and Sanders (5), it is
not surprising that inducible enzymes were not inhibited by
clavulanic acid. This is probably due to poor binding, as
reported by Cullman (3). The efficacy of tazobactam and
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sulbactam as inhibitors of inducible 13-lactamase was difficult to
assess because inducible organisms were all susceptible to
piperacillin and cefoperazone regardless of induction. More of
the constitutive organisms were susceptible when tazobactam
was present with piperacillin and when sulbactam was tested
with cefoperazone. As a result of induction of constitutive
organisms, only one organism acquired resistance to piperacil-
lin-tazobactam. None of 10 constitutive organisms was suscep-
tible to piperacillin, but 6 of 10 uninduced and 5 of 10 induced
organisms were susceptible to piperacillin-tazobactam. The
average zone sizes for the 10 organisms were 12 mm with
piperacillin and 17 mm with piperacillin-tazobactam, regard-
less of induction. Regardless of induction, none of 12 consti-
tutive organisms was susceptible to cefoperazone but 11 of 12
were susceptible to cefoperazone-sulbactam. The average zone
sizes were 15 mm for cefoperazone and 20 mm for cefopera-
zone-sulbactam. Thus, tazobactam and sulbactam make pip-
eracillin and cefoperazone more effective against constitutive
enterobacters, and efficacy is maintained with extremely high
,-lactamase levels. Cullman (3) reported that the inducible
P-lactamase of enterobacters has a higher binding affinity for
tazobactam than sulbactam. Our data seem to indicate the
reverse, but that may be due to the efficacy of the companion
antimicrobial agent or the combination rather than the affinity
of the inhibitor. The clinical efficacy of tazobactam and sulbac-
tam versus the inducible 3-lactamase of enterobacters remains
to be proven.
The cefoxitin inducer-cefuroxime indicator system works
well in unveiling latent inducible P-lactamase. Cefuroxime is
an ideal indicator in that induced ,B-lactamase caused resis-
tance while latent ,B-lactamase producers were susceptible.
Induced resistance to cefuroxime was sometimes, but not
always, accompanied by increased resistance to other broad-
and expanded-spectrum cephalosporins and ticarcillin in our
disk diffusion-induction studies. Inducible 1-lactamase was
uniformly detected by acquisition of resistance to cefuroxime,
and Seeberg et al. (18) and Ehrhardt and Sanders (5) have
stated that inducible ,-lactamase is responsible for the resis-
tance of enterobacters to expanded-spectrum cephalosporins.
We demonstrated the ability of crude lysates from induced
organisms to degrade ceftriaxone, cefotaxime, and ceftazidime.
Our cefoxitin inducer-cefuroxime indicator system is simple
enough to be employed in routine laboratory practice to
reliably identify organisms capable of producing inducible
1-lactamase and its implied resistance.
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